Product Information
DEXLANSOPRAZOLE DR 30 MG CAP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $4.1649 per EA under NDC 62332082330. Its NADAC has been published 18 times since Feb 25, 2026.
Strength
30 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332082330
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DEXLANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA219115On Market Since
11/14/2025
Pharmacological Classes
Price Statistics
The NADAC for DEXLANSOPRAZOLE DR 30 MG CAP has been published 18 times since Feb 25, 2026, and over the history we have for it it has declined 13.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.1649 per EA |
|---|---|
| All-time high | $4.8365 (Mar 11, 2026) |
| All-time low | $4.1649 (Jun 17, 2026) |
| 52-week high | $4.8365 |
| 52-week low | $4.1649 |
| Median price | $4.4485 |
| Average price | $4.4907 |
| Largest weekly change | -5.1% (May 20, 2026) |
| Weeks tracked | 18 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEXLANSOPRAZOLE DR 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXLANSOPRAZOLE DR 30 MG CAP, manufactured by Alembic Pharmaceuticals Inc., is $4.1649 per EA (NDC 62332082330), effective Jun 24, 2026.
How has the price of DEXLANSOPRAZOLE DR 30 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXLANSOPRAZOLE DR 30 MG CAP has declined 13.9%. It has been tracked across 18 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for DEXLANSOPRAZOLE DR 30 MG CAP?
Since Feb 25, 2026, the NADAC for DEXLANSOPRAZOLE DR 30 MG CAP has ranged from a low of $4.1649 (Jun 17, 2026) to a high of $4.8365 (Mar 11, 2026), with a median of $4.4485 per EA.
Are there cheaper alternatives to DEXLANSOPRAZOLE DR 30 MG CAP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DEXLANSOPRAZOLE DR 30 MG CAP, but none are currently priced below it.
Who manufactures DEXLANSOPRAZOLE DR 30 MG CAP?
DEXLANSOPRAZOLE DR 30 MG CAP (NDC 62332082330) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification